Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Paclitaxel (Actavis) 100 mg/16.67 mL injection, 16.67 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Plaxel 100 mg/16.67 mL injection, 16.67 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
B-Dose Forte (Biological Therapies) injection, 3 x 2.5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
B-Dose Forte (Biological Therapies) injection, 6 x 2.5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Noxafil 300 mg/16.7 mL injection, 16.7 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Keytruda (pembrolizumab 50 mg) powder for injection, 1 x 50 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Mycamine 50 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Mycamine 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Keppra IV 500 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cyklokapron 2 g/20 mL injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Entyvio 300 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fludara IV 50 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Emend IV 150 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Javlor 50 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Javlor 50 mg/2 mL injection, 10 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Javlor 250 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Javlor 250 mg/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Rixubis (1 x 500 units vial, 1 x 5 mL inert diluent vial), 1 pack, vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Rixubis (1 x 250 units vial, 1 x 5 mL inert diluent vial), 1 pack, vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Rixubis (1 x 2000 units vial, 1 x 5 mL inert diluent vial), 1 pack, vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Rixubis (1 x 1000 units vial, 1 x 5 mL inert diluent vial), 1 pack, vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Rixubis (1 x 3000 units vial, 1 x 5 mL inert diluent vial), 1 pack, vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Menveo (1 x MenA vial, 1 x MenCWY vial), 1 pack, vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Meropenem (Ranbaxy) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Meropenem (Ranbaxy) (meropenem 1 g) powder for injection, 5 x 1 g vials (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Meropenem (Ranbaxy) (meropenem 500 mg) powder for injection, 1 x 500 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Meropenem (Ranbaxy) 500 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Paclitaxel (Act) 150 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Paclitaxel (Act) 30 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Paclitaxel (Act) 300 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Paclitaxel (Act) 100 mg/16.67 mL injection, 16.67 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Sodium Selenate Decahydrate (Phebra) 467 microgram/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Sodium Selenate Decahydrate (Phebra) 111 microgram/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Botox 100 units powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Sodium Selenate Decahydrate (Phebra) 467 microgram/2 mL injection, 10 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Botox 200 units powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dysport 500 units powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dysport 300 units powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Retinofluor 10% 500 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Retinofluor 25% 1.25 g/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Retinofluor 10% (fluorescein sodium 1 g / 10 mL) injection, 10 x 10 mL vials (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Reandron-1000 1 g/4 mL modified release injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Metoprolol IV (Mylan) 5 mg/5 mL injection, 5 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Epirubicin Hydrochloride (Kabi) 10 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Imigran S 10 mg/actuation nasal spray, 2 x 1 actuation, vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Imigran 20 mg/actuation nasal spray, 2 x 1 actuation, vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Paclitaxel (GN) (paclitaxel 100 mg / 16.7 mL) injection, 1 x 16.7 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Paclitaxel (GN) 30 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Paclitaxel (GN) 300 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Zoledronic Acid (DBL) 4 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vimizim 5 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Inflectra 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Esomeprazole (Act) 40 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Zoledronic Acid (Apo) 4 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Tirostat 12.5 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Osteovan 5 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cyramza 100 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Zoledasta 5 mg/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Flucloxacillin (DBL) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (MYX) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Sandoz) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Elelyso 200 units powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (MYX) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Flubiclox 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Velcade 3 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Flubiclox 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (DBL) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (DBL) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Arginine Hydrochloride (Phebra) 60% (15 g/25 mL) injection, 10 x 25 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Apotex) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (DRLA) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Reladdin 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Reladdin 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Apotex) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Juno) (pemetrexed 100 mg) powder for injection, 1 x 100 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Juno) (pemetrexed 500 mg) powder for injection, 1 x 500 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (DBL) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Zerbaxa (ceftolozane 1 g + tazobactam 500 mg) powder for injection, 10 vials (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Mylan) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Mylan) 2 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftriaxone (Alphapharm) 2 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Mylan) (ceftazidime 1 g) powder for injection, 1 x 1 g vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Mylan) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ketamine (Hospira) 200 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Granisetron (Sandoz) 3 mg/3 mL injection, 3 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Granisetron (Sandoz) 1 mg/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Accord) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Accord) (pemetrexed 500 mg) powder for injection, 1 x 500 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pemetrexed (Accord) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Zolaccord 4 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cisatracurium (Accord) 10 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Astron) 20 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Taxoccord (docetaxel 80 mg / 4 mL) injection, 1 x 4 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Astron) 160 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Intas) 160 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Intas) 80 mg/4 mL injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Mayne) 80 mg/4 mL injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Mayne) 20 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Taxoccord 160 mg/8 mL injection, 8 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Docetaxel (Astron) 80 mg/4 mL injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Taxoccord 20 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|